¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Abnormal serum enzyme levels"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • angiotensin converting enzyme
    ¾ØÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
  • angiotensin converting enzyme inhibitor
    ¾ØÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦
  • antibody capture enzyme-linked immunosorbent assay
    Ç×üÆ÷ȹȿ¼Ò¸é¿ªÃøÁ¤(¹ý)
  • autolytic enzyme
    ÀÚ°¡¿ëÇØÈ¿¼Ò
  • adaptive enzyme
    ÀûÀÀÈ¿¼Ò
  • allosteric enzyme
    ¾Ë·Î½ºÅ׸®È¿¼Ò
  • blood enzyme level
    Ç÷ÁßÈ¿¼Ò³óµµ
  • brancher enzyme
    °¡ÁöÄ¡±âÈ¿¼Ò, ºÐÁöÈ¿¼Ò
  • branching enzyme
    °¡ÁöÄ¡±âÈ¿¼Ò, ºÐÁöÈ¿¼Ò
  • constitutive enzyme
    ±âº»±¸¼ºÈ¿¼Ò
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • cytosolic enzyme
    ¼¼Æ÷¾×È¿¼Ò
  • debrancher enzyme
    °¡ÁöÁ¦°ÅÈ¿¼Ò, Å»ºÐÁöÈ¿¼Ò
  • digestive enzyme
    ¼ÒÈ­È¿¼Ò
  • double-sandwich enzyme-linked immunosorbent assay
    °ãÈ¿¼Ò¸é¿ªÃøÁ¤(¹ý)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • serum typing
    Ç÷ûÇü°Ë»ç
  • specific serum
    ƯÀÌÇ÷û
  • standard serum
    ±âÁØÇ÷û
  • adaptive enzyme
    ÀûÀÀÈ¿¼Ò
  • allosteric enzyme
    ¾Ë·Î½ºÅ׸®È¿¼Ò
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
  • antibody capture enzyme-linked immunosorbent assay
    Ç×üÆ÷ȹȿ¼Ò¸é¿ªÃøÁ¤¹ý
  • autolytic enzyme
    ÀÚ°¡¿ëÇØÈ¿¼Ò
  • double-sandwich enzyme-linked immunosorbent assay
    °ãÈ¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme activity
    È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
  • enzyme assay
    È¿¼ÒÃøÁ¤
  • enzyme labeled antibody
    È¿¼ÒÇ¥ÁöÇ×ü
  • enzyme-linked immunosorbent assay
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • blood enzyme level
    Ç÷ÁßÈ¿¼Ò³óµµ
  • branching enzyme
    °¡ÁöÄ¡±âÈ¿¼Ò, ºÐÁöÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • reducing enzyme
    ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
  • regulatory enzyme
    Á¶ÀýÈ¿¼Ò(¡­ý£áÈ).
  • Cattanis serum
    īŸ´Ï¾×.
  • Cattanis serum
    īŸ´Ï¾×.
  • Cattanis serum
    īŸ´Ï¾×.
  • Cherons serum
    »þ·Î¿ìÇ÷û.
  • Glutamine-oxaloacetic transaminase, serum
    ±Û·çŽ¿Á»ì¾Æ¼¼Æ®»ê Ʋ¶õ½º¾Æ¹Ì³ªÁ¦
  • Ham test=acidified serum test
    ÇÜ °Ë»ç, »ê¼ºÈ­Ç÷û¿ëÇ÷°Ë»ç
  • Loefflers coagulated serum medium
    ·ÚÇ÷¯ÀÀ°íÇ÷û»ç¸é¹èÁö
  • Loefflers serum slant
    ·ÚÇ÷¯ Ç÷û»ç¸é¹èÁö
  • Luton s serum
    ·çÅæÇ÷û.
  • RISA=£¾radioiodinated serum albumin
    ¹æ»ç¼±¿ä¿ÀµåÇ÷û¾ËºÎ¹Î.
  • SPCA= serum prothrombin conversion a
    Ç÷ûÇÁ·ÎÆ®·ÒºóÀüÈ­ÃËÁø¼Ò.
  • U/S osmol ratio => urine/serum osmol ratio
    ¼Òº¯/Ç÷û ¿À½º¸ôºñ
  • acidified serum test
    »ê¼ºÈ­Ç÷û½ÃÇè(ß«àõûùúìôèãËúÐ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • horse anti serum thymocyte
    ¸»Ç×Ç÷ûÈä¼±¼¼Æ÷.
  • horse serum
    ¸»Ç÷û(?̴̧).
  • horse serum
    ¸»Ç÷û(¡­úìôè).
  • human serum immune globulin
    Àΰ£Ç÷û¸é¿ª±Û·ÎºÒ¸°.
  • human serum immune globulin
    Àΰ£Ç÷û¸é¿ª±Û·ÎºÒ¸°.
  • human serum immune globulin
    Àΰ£Ç÷û¸é¿ª±Û·ÎºÒ¸°.
  • human serum jaundice
    Àΰ£Ç÷ûȲ´Þ.
  • hyperimmune serum
    °íµµ¸é¿ªÇ÷û
  • icteric serum
    Ȳ´ÞÇ÷û
  • immune serum
    ¸é¿ªÇ÷û.
  • immune serum globulin
    ¸é¿ª Ç÷û ±Û·ÎºÒ¸°
  • immune serum globulin
    ¸é¿ªÇ÷û±Û·ÎºÒ¸°.
  • immune serum globulin transfusion
    ¸é¿ªÇ÷û±Û·ÎºÒ¸°¼öÇ÷
  • immunoglobulin G CSF/serum ratio
    ¸é¿ª±Û·ÎºÒ¸° G ³úô¼ö¾×/Ç÷û ºñ(À²)
  • inactivated serum
    ºñȰ¼ºÈ­Ç÷û.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • core enzyme
    ÇÙ½ÉÈ¿¼Ò(ú·ãýý£áÈ)
  • covalent enzyme-substrate complex
    È¿¼Ò±âÁú °øÀ¯°áÇÕü(ý£áÈÐñòõÍìêóÌ¿ùêô÷) (ÔÒ) enzymesubstrate compound
  • debranching enzyme
    °¡ÁöÁ¦°Å(ð¶ËÛ) È¿¼Ò(ý£áÈ)
  • depolymerizing enzyme
    ÇØÁßÇÕ È¿¼Ò(ú°ñìùêý£áÈ)
  • desensitized enzyme
    Å»°¨ÀÛÈ¿¼Ò(÷­ÊõíÂý£áÈ)
  • digestive enzyme
    ¼ÒÈ­È¿¼Ò(á¼ûùý£áÈ)
  • dispensable enzyme
    ºñÇʼö È¿¼Ò(Þªù±âÎý£áÈ) (ÔÒ) nonessential enzyme
  • DNA-relaxing enzyme
    DNAÀÌ¿Ï È¿¼Ò(ì¬èÐý£áÈ) (ÔÒ) topoisomerase
  • DNA restriction enzyme
    DNA Á¦ÇÑ È¿¼Ò(ð¤ùÚý£áÈ) (ÔÒ) restriction enzyme
  • drug-detoxication enzyme
    ¾à¹°Çص¶ È¿¼Ò(å·Úªú°Ô¸ý£áÈ) (ÔÒ) drug-metabolizing enzyme
  • drug-metbolizing enzyme
    ¾à¹°´ë»ç È¿¼Ò(å·ÚªÓÛÞóý£áÈ)
  • early enzyme
    Á¶±â È¿¼Ò(ðÄÑ¢ý£áÈ)
  • enzyme
    È¿¼Ò(ý£áÈ)
  • enzyme I
    È¿¼Ò(ý£áÈ) I
  • enzyme II
    È¿¼Ò(ý£áÈ) II
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ACA abnormal coronary artery; acrodermatitis chronica atrophicans; acute cerebellar ataxia; adenocarcino...
AF abnormal frequency; acid-fast; adult female; afebrile; aflatoxin; albumin-free; albumose-free; aldeh...
AGT abnormal glucose tolerance; activity group therapy; acute generalized tuberculosis; angiotensin; ant...
AGTT abnormal glucose tolerance test
AIMD abnormal involuntary movement disorder
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ACE Angiotensin converting enzyme activity
ACE inhibitor angiotensin converting enzyme inhibitor
ADEPT Antibody Directed Enzyme Prodrug Therapy
AOE anti-oxidant enzyme
CoA Co-enzyme A
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • phosphorylating enzyme
    ÀλêÈ­ È¿¼Ò
  • proteolytic enzyme
    ´Ü¹é ºÐÇØ È¿¼Ò
    ´Ü¹é ºÐÇØ¸¦ ÃËÁøÇÏ´Â È¿¼Ò.
  • Q enzyme
    Å¥ È¿¼Ò
    Æ÷µµ´ç-1-ÀλêÀÇ 1,6-C¿¡ ÀÛ¿ëÇÏ¿© À̰ÍÀ» ÁßÈ­½ÃŰ´Â È¿¼Ò.
  • rate-limiting enzyme
    ¼Óµµ Á¶Àý È¿¼Ò
  • receptor destroying enzyme
    ¼ö¿ëü ÆÄ±« È¿¼Ò
    ¼ö¿ëü¸¦ ÆÄ±«ÇÏ¿© ÀûÇ÷±¸ÀÇ ¹ÙÀÌ·¯½º ¿ëÇ÷¿¡ ´ëÇÑ °¨¼ö¼ºÀ» ÀÒ¾î¹ö¸®°Ô ÇÏ´Â È¿¼Ò.
  • splitting enzyme
    ºÐÇÒ È¿¼Ò
  • Z-enzyme
    ÁîÀÌ È¿¼Ò
    º£Å¸-¾Æ¹Ð¶óÁ¦¿Í Çù·ÂÇÏ¿© ¾Æ¹Ð·ÎÁ¦ÀÇ ¿ÏÀü ºÐÇØ¸¦ ÀÏÀ¸Å²´Ù.
  • acute phase serum
    ±Þ¼º º´±â Ç÷û
  • acute serum sickness
    ±Þ¼º Ç÷ûº´
    Àü½Å¼º ¸é¿ªº¹ÇÕü ÁúȯÀÇ ÀüÇüÀûÀÎ ¿¹ÀÌ´Ù. Çѵ¿¾È Çǵ¿¼º ¸é¿ªÀ» À§ÇØ »ç¿ëµÈ ´Ù·®ÀÇ ÀÌÁ¾ Ç÷ûÀÇ Åõ¿©¿¡ µû¸¥ ÈÄÀ¯ÁõÀÌ´Ù.
  • Banzhaf serum
    ¹ÝÃ÷ÇÏÇÁ Ç÷û
    ³óÃà Ç×Æó¿°±Õ Ç÷û.
  • Bardel's serum
    ¹Ù¾Æµ¨ Ç÷û
  • blood serum
    Ç÷û
    1. Ç÷¾×ÀÌ ¿ÏÀüÈ÷ ÀÀ°íµÈ ´ÙÀ½ Ç÷¾×¿¡¼­ À¯¸®µÈ Åõ¸íÇÑ ¾×ü·Î, ÀÀ°í °úÁ¤¿¡ À־ Ç÷ÀåÀ¸·ÎºÎÅÍ ¼¶À¯¼Ò¿øÀÌ Á¦°ÅµÈ °Í. 2. Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¿øÀ» Á¦°ÅÇÑ ³ª¸ÓÁö. »ýü¿¡¼­ äÃëÇÑ Ç÷¾×À» ½ÃÇè°ü¿¡ ³Ö¾î Á¶¿ëÈ÷ ¼¼¿öµÎ¸é ¸ÕÀú ÀÀ°íÇÏ¿© ÀÀÇ÷ÀÌ µÇ°í, À̰ÍÀÌ ¼öÃàÇÏ¿© ¾ÏÀû»öÀÇ µ¢¾î¸®ÀÎ Ç÷º´°ú ´ãȲ»öÀÇ Åõ¸íÇÑ ¾×üÀÎ Ç÷ûÀ¸·Î ³ª´©¾îÁø´Ù. Áï, Ç÷¾×¿¡¼­ À¯Çü ¼ººÐ ÀÌ¿ÜÀÇ ºÎºÐÀº Ç÷ÀåÀε¥, ÀÌ Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¿ø
  • foreign serum
    ÀÌÁ¾ Ç÷û
  • horse serum
    ¸» Ç÷û
    ¸»ÀÇ Ç÷¾×¿¡¼­ ¾ò¾îÁö´Â Ç÷û.
  • human serum immune globulin
    Àΰ£ Ç÷û ¸é¿ª ±Û·ÎºÒ¸°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
serum albumin <protein> The serum level of the low molecular protein albumin. Albumin, produced by the liver, plays an important role in maintaining plasma oncotic pressure. Normal serum albumin should be 3.5-5.0 grams per decilitre. Low serum albumin can be found in cases of liver disease and malnutrition.
(27 Sep 1997)
serum albumin, bovine Serum albumin from cows, commonly used in in vitro biological studies.
(12 Dec 1998)
serum albumin, radio-iodinated <chemical> Normal human serum albumin mildly iodinated with radioactive iodine (131-I) which has a half-life of 8 days, and emits beta and gamma rays. It is used as a diagnostic aid in blood volume determination.
Pharmacological action: radiopharmaceuticals.
(12 Dec 1998)
serum amyloid In secondary amyloidosis the fibrils deposited in tissues are unrelated to immunoglobulin light chains (in contrast to the situation in primary amyloidosis) and are made of amyloid A protein (AA protein). This is derived from serum amyloid A (SAA) that is the apolipoprotein of a high density lipoprotein and an acute phase protein. Partial proteolysis converts SAA into the pleated sheet configuration of the amyloid fibrils. Amyloid P protein is also found as a minor component of the fibrils (in both primary and secondary amyloidosis) and is derived from serum amyloid P that has similarity to C-reactive protein. The physiological role remains obscure.
(18 Nov 1997)
serum amyloid P component Precursor of amyloid component P, found in basement membrane. Member of the pentraxin family.
See: serum amyloid.
(18 Nov 1997)
serum bactericidal test Method of measuring the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy. It is used to monitor the therapy in bacterial endocarditis, osteomyelitis and other serious bacterial infections. As commonly performed, the test is a variation of the broth dilution test.
(12 Dec 1998)
serum bicarbonate A measure of the bicarbonate level in the blood based on a venipuncture specimen. The serum carbon dioxide is one of the normally reported values in the electrolytes profile. Lower levels of carbon dioxide indicate an acidosis. The normal level is 20 to 29 mEq/L. Lower than normal levels can indicate diabetic ketoacidosis, lactic acidosis, alcoholic ketoacidosis, kidney disease, renal failure, diarrhoea, Addison's disease, ethylene glycol poisoning or methanol poisoning. Greater than normal levels can be seen with excessive vomiting, hyperaldosteronism and Cushing's syndrome.
(27 Sep 1997)
serum cholinesterase <enzyme> A test which measures acetylcholinesterase and pseudocholinesterase, two enzymes which normally breakdown acetylcholine. Acetylcholinesterase is found in nerve tissue while pseudocholinesterase is found primarily in the liver. This test may be performed as a screening tool prior to the administration of electroconvulsive therapy (ECT). It is also useful in identifying organophosphate toxicity or congenital enzyme deficiencies.
(27 Sep 1997)
serum disease A hypersensitivity response (type III) to the injection of large amounts of antigen, as might happen when large amounts of antiserum are given in a passive immunisation. The effects are caused by the presence of soluble immune complexes in the tissues.
(18 Nov 1997)
serum erythropoietin <protein> Erythropoietin is a protein hormone which is produced by specialised cells in the kidneys. These cells are sensitive to low arterial oxygen concentration and will release erythropoietin when oxygen is low. Erythropoietin stimulates the bone marrow to produce more red blood cells (to increase the oxygen caring capacity of the blood). The measurement of this hormone in the bloodstream can indicate bone marrow disorders or kidney disease. Normal levels of erythropoietin are 0 to 19 mU/ml (milliunits per millilitre). Elevated levels can be seen in polycythaemia vera. Lower than normal values are seen in chronic renal failure.
(27 Sep 1997)
serum factor VIII antigen A test used to measure the activity of a blood clotting factor VIII (Von Willebrand factor). This test is usually used to monitor treatment of haemophilia. Abnormally low factor VIII assays may be seen in the following conditions: congenital deficiency of factor VIII (haemophilia), DIC and secondary fibrinolysis. This test may also be performed in the evaluation of Von Willebrand's disease.
(27 Sep 1997)
serum-fast 1. Pertaining to a serum in which there is little or no change in the titre of antibody, even under conditions of treatment or immunologic stimulation.
2. Resistant to the destructive effect of sera.
Synonym: serofast.
(05 Mar 2000)
serum ferritin <protein> A test that measures the amount of ferritin, a major iron storage protein. This test reflects the amount of iron stored in the body. Higher than normal values can be seen in haemochromatosis. Normal values for males: 12 to 300 ng/ml, females: 10 to 150 ng/ml.
(27 Sep 1997)
serum globulins All blood proteins except albumin ( = serum albumin, which is not a globulin) and fibrinogen (which is not in the serum). The serum globulins are subdivided into alpha-globulins, beta-globulins, and gamma-globulins on the basis of their electrophoretic mobilities.
(12 Dec 1998)
serum glutamic oxaloacetic transaminase <enzyme> An enzyme present in hepatocytes (liver cells) and heart cells. SGOT is released into the blood in larger quantities in cases where the heart or liver becomes damaged. Increased levels are usually associated with heart attacks or liver disease. Some medications can also raise blood SGOT levels. Another name for this test is the aspartate aminotransferase or AST.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á